Organització i avaluació de diàlegs polítics per al disseny de polítiques públiques en cronicitat: el cas de CHRODIS PLUS

Polítiques públiques; Malalties cròniques; CHRODIS PLUSPolíticas públicas; Enfermedades crónicas; CHRODIS PLUSPublic policies; Chronic diseases; CHRODIS PLUSL’objectiu d’aquest article és presentar la metodologia d’organització i avaluació dels diàlegs polítics, presentarne els resultats i extraure’n lliçons apreses que puguin servir per a un futur ús dels diàlegs polítics com a eina amb potencial en la definició de polítiques en salut

Eficacia y seguridad de la sanación espiritual activa: informe técnico

Sanación espiritual activa; Cuerpo energético; Técnica no invasivaSanació espiritual activa; Cos energètic; Tècnica no invasivaActive spiritual healing; Energy body; Non-invasive techniqueEste informe se centra en la aplicación de la “sanación espiritual activa” en las indicaciones para las cuales se han encontrado estudios en revistas indexadas, siendo artritis reumatoide la única indicación por la cual se ha encontrado evidencia de un estudio de alta calidad científica (ECA)1 .Para otras indicaciones más habituales del uso de la técnica (dolor inespecífico y/o crónico, problemas mentales y fatiga) sólo se ha incluido un estudio de menor calidad metodológica (observacional) en la discusión, con el fin central de ofrecer datos sobre la seguridad de la técnica, información inexistente en el único ECA incluido en el informe.This report focuses on the application of the “active spiritual healing” in the indications for which studies have been found in indexed journals, being rheumatoid arthritis the only indication for which evidence has been found in a high scientific quality (RCT)2 study. For other more common indications on the use of the technique (unspecific pain and/or chronic, mental problems and fatigue), only a lower methodological (observational) quality study has been included in the discussion, with the main aim of offering data on the safety of the technique, non-existent information in the only RCT included in the report

Evaluación de tecnología basada en mSalud para aplicaciones móviles

mSalud; Aplicaciones móviles; Tecnologías sanitarias; EvaluaciónmHealth; Mobile applications; Health technologies; EvaluationmSalut; Aplicacions mòbils; Tecnologies sanitàries; AvaluacióLa actual proliferación del uso de tecnologías de mSalud en el campo de la promoción de la salud y la prevención y/o el control de enfermedades ha hecho necesario el diseño de marcos evaluativos que permitan conocer su aceptabilidad, factibilidad, usabilidad, validez, fiabilidad o sus potenciales efectos sobre variables de salud. La aplicación de estos marcos evaluativos a aplicaciones móviles es indispensable para pilotar su adecuación y viabilidad. El objeto de este desarrollo metodológico es proponer una herramienta para la evaluación de tecnologías sanitarias de mSalud.The current proliferation of the use of mHealth technologies in the field of health promotion and prevention and/ or disease control requires the necessity to design evaluation frameworks to know their acceptability, feasibility, usability, validity, reliability or their potential effects on health variables. The application of evaluation frameworks to assess the quality of mobile solutions is essential to pilot their suitability and viability. The objective of this methodological development is to propose a tool for the evaluation mHealth solutions.L’actual proliferació de l’ús de tecnologies de mSalud en el camp de la promoció de la salut i la prevenció i/o el control de malalties ha fet necessari el disseny de marcs avaluatius que en permetin conèixer l’acceptabilitat, factibilitat, usabilitat, validesa, fiabilitat o els efectes potencials sobre variables de salut. L’aplicació d’aquests marcs avaluatius en aplicacions mòbils és indispensable per pilotar-ne l’adequació i la viabilitat. L’objecte d’aquest desenvolupament metodològic és proposar una eina per a l’avaluació de tecnologies sanitàries de mSalud

Daily sitting time and its association with non-communicable diseases and multimorbidity in Catalonia

Background: Non-communicable diseases (NCDs) account for 71% of deaths worldwide and individual behaviours such as sedentariness play an important role on their development and management. However, the detrimental effect of daily sitting on multiple NCDs has rarely been studied. This study sought (i) to investigate the association between sitting time and main NCDs and multimorbidity in the population of Catalonia and (ii) to explore the effect of physical activity as a modifier of the associations between sitting time and health outcomes. Methods: Cross-sectional data from the 2016 National Health Survey of Catalonia were analyzed, and multivariable logistic regression, adjusting for socio-demographics and individual risk factors (tobacco and alcohol consumption, diet, hyperlipidaemia, hypertension, body mass index) was used to estimated odds ratios (ORs) and 95% confidence intervals (CIs) of the association between sitting time and NCDs. Results: A total of 3320 people 15 years old were included in the study. Sitting more than 5 h/day was associated with a higher risk of cardiovascular disease (OR 1.90, 95% CI: 1.21-2.97), respiratory disease (OR 1.61, 95% CI: 1.13-2.30) and multimorbidity (OR 2.80, 95% CI: 1.53-5.15). Sitting more than 3 h/day was also associated with a higher risk of multimorbidity (OR 2.26, 95% CI: 1.23-4.16). Physical activity did not modify the associations between sitting time and any of the outcomes. Conclusions: Daily sitting time might be an independent risk factor for some NCDs, such as cardiovascular disease, respiratory disease and multimorbidity, independently of the level risk of physical inactivity

Shaping Policy on Chronic Diseases through National Policy Dialogs in CHRODIS PLUS.

Policy dialogs are deliberative dialogue that gather policy makers and relevant stakeholders from across disciplines to discuss a topic of mutual interest. They typically serve as a single element in a broader policymaking cycle, either informing the content of new policy or forming a component of policy evaluation and review. In the joint action CHRODIS PLUS, national policy dialogs were conducted in fourteen EU Member States. The aim of the dialogs was to identify new policies or changes to existing policies and legislation that are capable of tackling major risk factors for chronic disease, to strengthen health promotion and prevention programs and to ensure health systems are equipped to respond to priority issues within the chronic diseases field. In this paper, we present the CHRODIS PLUS policy dialog methodology, as well as results and lessons learnt from three national policy dialogs held in Ireland, Portugal and Spain. After discussion of the results, we conclude that the CHRODIS PLUS methodology is an effective mechanism to provoke deliberative discussion around chronic disease prevention and management in different countries. However, it is essential to ensure adequate human and financial resources-as well as political commitment-to accomplish objectives set out during the policy dialogs. We argue that priority-setting across sectors can improve the resilience of health systems and opportunities for investment in Health in All Policies (HiAP), both at European Union and Member State levels.This research was funded by the European Union, in the framework of the Health Program (2014–2020) Grant Number 761307S

A Methodological Approach for Implementing an Integrated Multimorbidity Care Model: Results from the Pre-Implementation Stage of Joint Action CHRODIS-PLUS

Patients with multimorbidity (defined as the co-occurrence of multiple chronic diseases) frequently experience fragmented care, which increases the risk of negative outcomes. A recently proposed Integrated Multimorbidity Care Model aims to overcome many issues related to fragmented care. In the context of Joint Action CHRODIS-PLUS, an implementation methodology was developed for the care model, which is being piloted in five sites. We aim to (1) explain the methodology used to implement the care model and (2) describe how the pilot sites have adapted and applied the proposed methodology. The model is being implemented in Spain (Andalusia and Aragon), Lithuania (Vilnius and Kaunas), and Italy (Rome). Local implementation working groups at each site adapted the model to local needs, goals, and resources using the same methodological steps: (1) Scope analysis; (2) situation analysis-"strengths, weaknesses, opportunities, threats" (SWOT) analysis; (3) development and improvement of implementation methodology; and (4) final development of an action plan. This common implementation strategy shows how care models can be adapted according to local and regional specificities. Analysis of the common key outcome indicators at the post-implementation phase will help to demonstrate the clinical effectiveness, as well as highlight any difficulties in adapting a common Integrated Multimorbidity Care Model in different countries and clinical settings